Stock Earnings
Analysts review Avadel Pharmaceuticals plc’s rating
Avadel Pharmaceuticals plc’s filing revealed that its Director Palczuk Linda acquired Company’s shares for reported $39640.0 on Jan 21 ’25.
Menu
Avadel Pharmaceuticals plc’s filing revealed that its Director Palczuk Linda acquired Company’s shares for reported $39640.0 on Jan 21 ’25.
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Avadel Pharmaceuticals plc’s recent filing unveils that its Director Palczuk Linda acquired Company’s shares for reported $39640.0 on Jan 21
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Avadel Pharmaceuticals
In a filing, Avadel Pharmaceuticals plc revealed its Director Palczuk Linda acquired Company’s shares for reported $39640.0 on Jan 21
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Avadel Pharmaceuticals plc’s recent filing unveils that its Director Palczuk Linda acquired Company’s shares for reported $39640.0 on Jan 21
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Avadel Pharmaceuticals